The Times Australia
The Times World News

.

Why the pathology bulk-billing campaign is more about driving industry profits than saving you money

  • Written by Stephen Duckett, Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Why the pathology bulk-billing campaign is more about driving industry profits than saving you money

For many people, the term “bulk billed” refers to a GP visit they don’t have to pay for out-of-pocket. But another form of bulk billing is in the news ahead of May’s federal budget – bulk billing of pathology testing, such as blood tests.

This relates to the fees pathology companies receive from Medicare to perform out-of-hospital laboratory tests, the type your GP might order to help diagnose or monitor disease.

These pathology fees have been frozen for almost a quarter of a century[1]. Is that fair? Obviously not, argues Australian Pathology[2], which represents private pathology laboratories.

It has recently launched its “Keep Pathology Bulk Billed[3]” campaign. At the core is a request for about an extra A$160 million[4] a year for pathology companies. It argues this is needed to keep most out-of-hospital pathology tests free for the public.

But simple solutions put forward by vested interests involving more public funds are rarely in the public interest. Here’s how we might design a fairer pathology system, fit for the 21st century, that keeps tests free for the public.

Read more: Medicare turns 40: since 1984 our health needs have changed but the system hasn't. 3 reforms to update it[5]

Pathology is big business

Collecting specimens and analysing them is big business. Pathology providers received almost $3.25 billion[6] for out-of-hospital tests in 2022-23 from Medicare rebates. Pathology testing is also conducted in public and private hospitals, but these are funded under a combination of different arrangements.

Almost all (more than 99%) of out-of-hospital pathology services are bulk billed. That’s a rate much higher than that for GP visits, which stood at about 80% in the same period.

Pathology use is increasing faster[7] than the population is growing. That’s partly because of more chronic disease in the population, and partly because new tests are becoming available.

Pathology provision is concentrated in a few hands, with a number of providers listed on the Australian Stock Exchange[8]. Increases in pathology rebates, as Australian Pathology is calling for, would go straight to companies’ bottom lines, increasing shareholder value.

Drive-through COVID testing
Remember drive-through testing? In the early days of the pandemic, private pathology companies conducted millions of COVID PCR tests. Christie Cooper/Shutterstock[9]

So why are pathology companies calling for more funding now? Pathology companies’ profits burgeoned[10] during the first years of the COVID pandemic, with the introduction of widespread PCR testing and the government funding that went with it.

But the industry was accused of profiting from “COVID-19 misery[11]”, and the gravy train eventually ended[12]. So pathology companies are now looking to replace that revenue, using the latest campaign to try to increase rebates.

Read more: Worried about getting a blood test? 5 tips to make them easier (and still accurate)[13]

Does the pathology industry have a point?

On the face of it, a 24-year freeze on pathology government rebates might seem unfair. But a look into the pathology world reveals an industry where there has been significant productivity growth[14].

An increased volume of standard tests, as we’ve seen in recent years, can lead to improved productivity. For instance, companies can work their testing equipment harder – running them for longer, loading them with more samples – lowering the cost per test. Improvements in equipment also allow tests to be done quicker, allowing increased economies of scale.

But a fee freeze is a lazy policy, an example of “set and forget”. While it does achieve some benefits for the taxpayer, it’s not optimal. That’s because it assumes all the productivity savings (from automation, digitisation and increased economies of scale) exactly offset any increased costs from inflation. This is never likely to be true. Given the current extent of automation and consolidation, this is probably leaving excess profits in the pockets of providers, and costing governments more than they need to pay.

More changes[15] in pathology provision are yet to come. Advances in artificial intelligence[16] are accelerating and automated reading of some pathology tests may reduce pathology costs further, yielding more profits for providers.

Future policies need to reflect changes in how much it costs to provide pathology services, details of which are thin on the ground.

Read more: AI can help detect breast cancer. But we don't yet know if it can improve survival rates[17]

What needs to happen?

Government should step back and ask whether a fees-for-pathology-service payment system, designed a century ago when pathology provision was literally a cottage industry, is still right in an era of extensive automation and ownership concentration. The answer is clearly no.

Reform should first dump the existing uncapped, fee-for-service payment system. Pathology is a big business and should be paid as such using tenders and contracts[18].

Two people looking at a document, one about to sign it Pathology providers should be invited to tender for contracts, to keep costs down. fizkes/Shutterstock[19]

Pathology companies should be invited to tender to provide out-of-hospital pathology services in designated geographic areas. Two or more tenders could be approved to maintain competition between providers and keep options open for the end of the tender period. Pathology contracts should involve no out-of-pocket payments by consumers.

In-hospital pathology should not be covered by the same arrangements. Instead, private hospitals should make their own contractual arrangements for pathology provision, as they do now.

Public pathology services – run by state governments or their agencies such as Pathology Queensland[20] – are also changing.

Consolidation of public pathology services in New South Wales yielded significant improvements[21] in productivity. Victoria has started a less ambitious reform process, consolidating into three public providers[22] rather than the single public provider model seen in NSW, Queensland and South Australia. This will also probably yield savings.

Public providers should be invited with private providers into the tender process to enhance competition.

What’s the take-home message?

The world of pathology provision is in flux, with more changes on the horizon, whether that’s related to technology or consolidation. In this environment, paying more to private providers under a payment system that has passed its use-by date is not good policy. That’s despite its simplistic attraction and advocacy from vested interests.

So the next time you go to a pathology collection centre and see posters encouraging you to email your MP to “keep pathology bulk billed”, beware. The campaign is more about company profits than saving you money.

References

  1. ^ almost a quarter of a century (www.ama.com.au)
  2. ^ Australian Pathology (www.australianpathology.com)
  3. ^ Keep Pathology Bulk Billed (keeppathologybulkbilled.com.au)
  4. ^ A$160 million (keeppathologybulkbilled.com.au)
  5. ^ Medicare turns 40: since 1984 our health needs have changed but the system hasn't. 3 reforms to update it (theconversation.com)
  6. ^ $3.25 billion (www.health.gov.au)
  7. ^ faster (publicpathology.org.au)
  8. ^ Australian Stock Exchange (asx.swingtradebot.com)
  9. ^ Christie Cooper/Shutterstock (www.shutterstock.com)
  10. ^ profits burgeoned (theconversation.com)
  11. ^ COVID-19 misery (msav.org.au)
  12. ^ ended (www.marketindex.com.au)
  13. ^ Worried about getting a blood test? 5 tips to make them easier (and still accurate) (theconversation.com)
  14. ^ productivity growth (www.elitelearning.com)
  15. ^ More changes (www.uq.edu.au)
  16. ^ artificial intelligence (www.ncbi.nlm.nih.gov)
  17. ^ AI can help detect breast cancer. But we don't yet know if it can improve survival rates (theconversation.com)
  18. ^ using tenders and contracts (grattan.edu.au)
  19. ^ fizkes/Shutterstock (www.shutterstock.com)
  20. ^ Pathology Queensland (www.health.qld.gov.au)
  21. ^ significant improvements (apo.org.au)
  22. ^ three public providers (www.austin.org.au)

Read more https://theconversation.com/why-the-pathology-bulk-billing-campaign-is-more-about-driving-industry-profits-than-saving-you-money-228091

Times Magazine

Building a Strong Online Presence with Katoomba Web Design

Katoomba web design is more than just creating a website that looks good—it’s about building an online presence that reflects your brand, engages your audience, and drives results. For local businesses in the Blue Mountains, a well-designed website a...

September Sunset Polo

International Polo Tour To Bridge Historic Sport, Life-Changing Philanthropy, and Breath-Taking Beauty On Saturday, September 6th, history will be made as the International Polo Tour (IPT), a sports leader headquartered here in South Florida...

5 Ways Microsoft Fabric Simplifies Your Data Analytics Workflow

In today's data-driven world, businesses are constantly seeking ways to streamline their data analytics processes. The sheer volume and complexity of data can be overwhelming, often leading to bottlenecks and inefficiencies. Enter the innovative da...

7 Questions to Ask Before You Sign IT Support Companies in Sydney

Choosing an IT partner can feel like buying an insurance policy you hope you never need. The right choice keeps your team productive, your data safe, and your budget predictable. The wrong choice shows up as slow tickets, surprise bills, and risky sh...

Choosing the Right Legal Aid Lawyer in Sutherland Shire: Key Considerations

Legal aid services play an essential role in ensuring access to justice for all. For people in the Sutherland Shire who may not have the financial means to pay for private legal assistance, legal aid ensures that everyone has access to representa...

Watercolor vs. Oil vs. Digital: Which Medium Fits Your Pet's Personality?

When it comes to immortalizing your pet’s unique personality in art, choosing the right medium is essential. Each artistic medium, whether watercolor, oil, or digital, has distinct qualities that can bring out the spirit of your furry friend in dif...

The Times Features

NSW has a new fashion sector strategy – but a sustainable industry needs a federally legislated response

The New South Wales government recently announced the launch of the NSW Fashion Sector Strategy, 2025–28[1]. The strategy, developed in partnership with the Australian Fashion ...

From Garden to Gift: Why Roses Make the Perfect Present

Think back to the last time you gave or received flowers. Chances are, roses were part of the bunch, or maybe they were the whole bunch.   Roses tend to leave an impression. Even ...

Do I have insomnia? 5 reasons why you might not

Even a single night of sleep trouble can feel distressing and lonely. You toss and turn, stare at the ceiling, and wonder how you’ll cope tomorrow. No wonder many people star...

Wedding Photography Trends You Need to Know (Before You Regret Your Album)

Your wedding album should be a timeless keepsake, not something you cringe at years later. Trends may come and go, but choosing the right wedding photography approach ensures your ...

Can you say no to your doctor using an AI scribe?

Doctors’ offices were once private. But increasingly, artificial intelligence (AI) scribes (also known as digital scribes) are listening in. These tools can record and trans...

There’s a new vaccine for pneumococcal disease in Australia. Here’s what to know

The Australian government announced last week there’s a new vaccine[1] for pneumococcal disease on the National Immunisation Program for all children. This vaccine replaces pr...